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Abstract

COMPARISON OF INJECTION DISCOMFORT AND ANESTHETIC DURATION OF
PLAIN POLOCAINE VERSUS EPINEPHRINE CONTAINING ARTICAINE AND
LIDOCAINE
By Dana Doan, DDS
A thesis submitted in partial fulfillment of the requirements for
the degree Master of Science at Virginia Commonwealth University.
Virginia Commonwealth University, 2013
Director: Dr. Tegwyn H. Brickhouse, DDS, PhD.
Chair, Department of Pediatric Dentistry

Purpose: To determine possible differences in the pain level and soft tissue anesthesia
duration of plain polocaine versus epinephrine-containing articaine and lidocaine during intraoral
injections.
Methods: Forty-eight subjects received plain polocaine and one epinephrine-containing
anesthetic. Injections were randomized according to the first injection a)left or right buccal
sulcus and b)epinephrine or not. The second injections were the opposite conditions. Subjects
then recorded discomfort on a VAS and the time anesthesia wore off.
Result: The second injection’s pain rating was influenced by the first. This carry-over
effect makes it impossible to analyze all of the data. An analysis of the first injection showed no

significant difference between the three anesthetics. The duration of anesthesia for epinephrinecontaining anesthetic was significantly longer than plain polocaine.
Conclusion: This pilot study was intended to create a sample size for a pediatric
population. However, due to the carry-over effect, future split-mouth studies may not be
justified.

Introduction
The advent of local anesthetic heralded a new era of patient comfort in dentistry.
However, it is an irony that local anesthetic injection enables painless work in the oral cavity, but
also provokes high anxiety and fear in patients. Fear due to perceived discomfort from injections
is considered one of the main reasons for dental anxiety.1 Successfully administered local
anesthesia allows the dentist to nurture the relationship with the patient, proceed with the
appointment, and to complete the therapeutic procedure while providing a pleasant experience.
There are a number of factors that can influence the discomfort of a dental injection such
as pH buffering of anesthetic solution, heating of anesthetic solution, applying pressure,
controlling the speed of injection, use of appropriate needle gauge, use of relaxation techniques,
use of topical anesthetic, use of aspirating syringe, and explanation of the procedure.2
Parameters relating to materials, but independent of technique that might affect pain at delivery
include the temperature and pH of the solution. Buffering the solution with sodium bicarbonate
can reduce the injection discomfort.3 However, this is not practical when prefilled dental
cartridges are used. Therefore, pH-dependent factors can be influenced by the choice of
anesthetic; for example plain polocaine solutions have a pH closer to physiological pH compared
with those that contain epinephrine.4 Plain local anesthetic solutions may cause less injection
discomfort compared to epinephrine-containing local anesthetic.
Plain polocaine has also been found to be equivalent to other epinephrine containing local
anesthetics for achieving pulpal anesthesia.5, 6 Although epinephrine in local anesthetic solutions
are beneficial in regards to duration, this could be considered a disadvantage as well.
1

Vasoconstriction leads to soft-tissue anesthesia that lasts several hours beyond completion of
treatment.7 This can lead to attenuated capability to speak, eat, drink, or smile. Especially in
children, accidental biting of the lips, cheeks, or tongue could cause soft-tissue damage.7
Therefore decreasing the post-operative duration of soft-tissue anesthesia could decrease this
adverse effect. To reduce the incidence of such soft-tissue injury, some clinicians use 3%
polocaine instead of 2% lidocaine-epinephrine.8 One study found a statistically significant
difference in the duration of soft-tissue for articaine with epinephrine (140.69±49.76 minutes) as
opposed to plain polocaine (117.52±42.99 minutes).9
The majority of current studies on plain versus epinephrine-containing local anesthetic
solution have been focused on its effect on cardiac patients.10 Meechan and Day did a study
comparing injection discomfort levels produced by two solutions on 24 subjects (ages 20 to 24)
in which they found plain lidocaine produces less discomfort than lidocaine with epinephrine
when administered into the maxillary premolar buccal surface. 4 However, Meechan and Day
used the traditional method of injection with short needles and aspirating syringes which did not
control for injection speed, pressure, or penetration depth.
An available marketed technology, The Wand (Dental Practice Systems, Herts, UK), uses
a microprocessor and an electronically controlled motor to deliver the anesthetic solution through
a handpiece with a needle at a constant rate and under controlled pressure. Most current studies
have found no difference in the pain or anxiety experienced in the conventional and Wand
group.11 However, some concluded block anesthesia seems to be less painful when using the
Wand than when using a traditional syringe.1 Delivery of the anesthetic solution via the Wand is
activated with a foot pedal and the thin, light handpiece with a needle held in a pen-like grasp
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helps to avoid variation in pressure during injection of anesthetic.1 The Wand will be used in
this study to control for injection speed and pressure.
Specific Aim
The goal of this randomized, double-blind, split-mouth study is to determine whether
there is a difference in the perceived pain level and soft tissue anesthesia duration of plain
polocaine versus epinephrine-containing articaine and lidocaine during intraoral injection with
The Wand.
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Methods
This study, which modeled the study done by Meechan and Day, was a pilot study carried
out on Virginia Commonwealth subjects. Adult human subjects are more able to give an
accurate pain response than children12 and the information obtained from this pilot study will be
used to create an appropriate sample size for the second part of this study, the pediatric
population. The study design was a double blind crossover study in which compared plain
polocaine to the two most frequently used local anesthetics in pediatric dentistry, 2% lidocaine
with 1:100,000 epinephrine and 4% articaine with 1:100,000 epinephrine.13 Each subject
received plain polocaine and either epinephrine-containing lidocaine or articaine in a randomized
order with the Wand.
Forty-eight students (24 men, 24 women) between the ages of 22 and 32 volunteered for
this pilot study after it was approved by the Institutional Review Board. Subjects over 35 years
of age, on any analgesic within the previous 72 hours, with any acute/chronic systemic
conditions, especially neurologic conditions, pregnant, and known allergies to drugs used in this
study were excluded. Students were fully informed of the purpose of the study, their research
related duties, and written consents and a health history form were completed. A power analysis
from the Meechan and Day study indicated that a sample size of 24 subjects provided a 90%
chance of detecting a 10-mm difference on the visual analogue scale (VAS) at the 1% level of
significance. We had 48 subjects equally divided amongst the two anesthetic studies, comparing
plain polocaine to epinephrine-containing lidocaine and plain polocaine to epinephrinecontaining articaine.
4

A pack of 3% plain polocaine, 2% lidocaine containing 1:100,000 epinephrine, and 4%
articaine containing 1:100,000 epinephrine were obtained (Southern Anesthesia, West Columbia,
South Carolina, USA). To maintain double-blind conditions, research assistants who were not
directly involved in the delivery of local anesthetic solutions removed the product identification
label from each cartridge and replaced it with a color-coded sticker. The stickers had the subject
number, either “1” for 1st injection or “2” for second injection, and either “L” for left or “R” for
right. Therefore, the cartridges were identical except for the color-coded sticker found on each
cartridge. The pH of a sample of each solution from the same batch numbers was measured on
an electronic pH meter (Mettler Toledo, Columbus, Ohio, USA) to verify the manufactuers’
reported pH level.
Injections were randomized according to whether the first injection was a) on the left or
right buccal sulcus in the maxillary first premolar region and b) epinephrine or not. The second
injection was the opposite site and used the other condition. There were four double blind
randomly assigned injection sequence groups as follows for each study:
1) left side, no epinephrine
2) left side, epinephrine
3) right side, no epinephrine
4) right side, epinephrine
Subjects were randomized using a computer generated sequence to insure equal group sizes.
The same operator, who was blinded to the identity of the solutions, gave all the
injections at room temperature. Through pre-trial measurements, the quantity of solution
injected was 0.84 mL over 30 seconds. For reasons of simplicity, palatal or other types of
injections were not included. No topical anesthetic was applied before injection because this
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added an uncontrolled variable to the study. Also, some studies have shown no significant
difference between the placebo and any topical anesthetic.14 The Wand was used throughout and
the 30 gauge, 1 inch needle was inserted the same depth into the injection site. To control the
depth of penetration into the maxillary buccal sulcus, the Wand handpiece with a half inch
needle was inserted into the barrel of an UltraSafe aspirating syringe (Safety Syringe, Carlsbad,
California, USA) (no longer available) which only allows the needle of the Wand to extrude the
same length of 3mm out the tip of the syringe.
Immediately after each local anesthetic administration, the subjects recorded injection
discomfort on a continuous 100-mm VAS with endpoints “no pain” and “unbearable pain.” The
subjects received a form with the time the anesthetic was delivered and instructed to record the
time soft-tissue anesthesia had worn off for both sides. Differences between solutions, left
versus right sides, and first versus second order effects were analyzed using Student's paired t
test modified to reflect the crossover design of the two sets of comparison groups. Differences
were considered significant when P<05. Specifically, a repeated-measured mixed-model
ANOVA was performed for each outcome (pain and time) with effects in the model to test for
differences between the two sets of anesthesia pairs, accounting for differences also due to
injection order and side of mouth.
After the results from the pilot study are obtained and analyzed, a similar study will be
carried out on a pediatric population if the results are significant and pending approval by the
Institutional Review Boards. Parents will provide written informed consent on behalf of their
children and children will provide verbal assent to participate. An appropriate sample size of
children between the ages of 7 and 1815 who require restorative treatment without pulp
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involvement of one or more deciduous molars per sides of the maxillary arch will be
administered anesthetic injections with identical protocols developed in this pilot study.
Statistical Methods
Study subjects were randomized into four sequence groups, per study. Since this
randomized, double-blind, split-mouth crossover study had multiple measures per subject, a
repeated-measures mixed-model ANOVA was used to compare the VAS pain and the numbness
duration across the study groups. Depending upon the outcomes measured, the ANOVA may
have included effects for Study (articaine versus polocaine, lidocaine versus polocaine),
sequence (Artic Polo, Polo Artic, Lido Polo, Polo Lido), side (left, right), or rater (1, 2). All
analyses were performed using SAS software (version 9.3, SAS Institute Inc., Cary NC).
Significance was declared at alpha=0.05.

7

Results
The pH of the plain polocaine solution was 6.4; the epinephrine-containing lidocaine and
articaine was 4.7 and 3.6 respectively.
Overview
First, the subjects included in the study groups will be described. Followed by the
analysis of the VAS pain scores in two parts. The first part will show how the second injection’s
pain rating was influenced by the first injection. This carry-over effect in the crossover study
makes it impossible to analyze all of the data using conventional crossover analysis. In the
second part, an analysis of the results from the first injection will be shown. Lastly, the
numbness duration will be analyzed.
Description of subjects
48 subjects were screened for inclusion in the study, met the inclusion criteria, and
consented to participate in the study. The average age of the subjects was 26 (SD = 2.35, range
= 22 to 32) with each gender represented at 50%. There were equal numbers of subjects
assigned to the 2 study groups. However, due to operator error resulting in two subjects being
assigned to incorrect groups, 23 subjects were in the articaine versus polocaine study and 25
were in the lidocaine versus polocaine study. All subjects received both injected anesthetics in a
random order and a random side. The number of subjects in each ordering group is shown in
Table 1. For example, there were 7 subjects who first received an articaine injection on the left
side, and therefore received the subsequent polocaine injection, on the right side. As may be
8

seen, there were approximately equal numbers of injection orders in each study. Since the study
assignment and order were randomly assigned, there should have been no differences depending
upon the sex or age of the subjects and the findings in this study were in agreement (P > 0.4).
Analysis of pain VAS
The primary outcome was the rating of pain, which was measured by two observers.
There was never more than one unit of difference between the two observers. The first observer
reported slightly higher pain scores (mean difference = 0.08, SE = 0.032) but the difference was
not significant (paired t-test P = 0.0579).
The goal of this randomized, double-blind, split-mouth study was to determine if there
was a difference in the perceived pain level and soft tissue anesthesia duration of plain polocaine
versus epinephrine-containing articaine and lidocaine during intraoral injection with The Wand.
Table 2 shows the results for each study. In a crossover design, each subject received both
interventions and therefore served as their own control. Subjects are randomized to one of two
sequences; in the articaine versus polocaine study, 12 subjects received the articaine injection
first and then the polocaine injection (sequence = “Artic Polo”) and 11 subjects received the
polocaine injection first and then the articaine injection (sequence = “Polo Artic”). This design
works as long as there is no order effects; that is, when the order of the injections does not affect
the pain rating. As seen in Table 2, this does not seem to be the case. When receiving articaine
first, the difference between the articaine pain minus the polocaine pain was –1.00. The
difference between the articaine pain minus the polocaine pain was +3.41 when receiving
polocaine first. When receiving lidocaine first, the difference between the lidocaine pain minus
the polocaine pain was –6.69. The difference between the lidocaine pain minus the polocaine
pain was +6.38 when receiving polocaine first. This “carry-over effect” confounds the
9

estimation of the effect of the injection. That is, it was impossible to use all the data to
determine whether there was a difference in the perceived pain level of plain polocaine versus
epinephrine-containing articaine and lidocaine.
In the analyses that follow, we will test for a significant carry-over effect and, if it is
present, the best that can be done is to analyze only the first injection. The parallel coordinate
plots of Figure 1 show one line for each subject and a red line for the average across all subjects
in that group. Figure 1(a) and 1(b) are those in the articaine versus polocaine study. The plot in
figure 1(a) shows the average trending weakly upward and the plot in figure 1(b) shows the
average trending weakly downward. In figure 1(c) and 1(d), the subjects in the lidocaine versus
polocaine study are shown. The plot in figure 1(c) shows almost all the subjects sloped upward
and in the figure 1(d) plot almost all the subjects sloped downward. If there had been no carryover effect, the lines should have trended in the same direction. That is, if order did not matter,
the slope of the lines representing the effect of epinephrine versus no epinephrine would have
been similar. They were not.
The VAS pain levels were analyzed using a repeated-measures mixed-model ANOVA
with the following factors: study (articaine versus polocaine, lidocaine versus polocaine),
sequence (Artic Polo, Polo Artic, Lido Polo, Polo Lido), side (left, right), and rater (1, 2). The
results shown in Table 3 showed there was a significant carry-over effect (P < .0001). This is
seen in the interaction test, “Inject*Sequence(Study)”; this test asked if the effect of the two
injections were the same across the two sequences used within each study. Also evident if the
data in Table 2, the difference between the injection containing epinephrine and that without
epinephrine was different depending upon which injection came first.
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The averages for each group’s VAS pain score are given in Table 4 and include 95%
confidence intervals and P-values comparing the two injections within each sequence. For the
articaine versus polocaine subjects there was no difference between the two injection order
groups, “Artic Polo” sequence (P = 0.554) and “Polo Artic” sequence (P = 0.099). However, the
signs for the differences were reversed in the two sequences, an indication of a carry-over effect.
See Figure 2 for an illustration of this reversal. For the lidocaine versus polocaine subjects, there
were similar results as in the articaine versus polocaine subjects with respect to the signs
indicating a carry-over effect. Again, the signs for the differences in the two sequences were
opposite, which indicates a carry-over effect. With clear indication that the second pain rating is
influenced by the first, the second injection data cannot be used to answer the aim of the study.
The best that can be done is to analyze only the first injection’s data.
A repeated-measures mixed-model ANOVA was run with the following factors
considered: Injection (articaine, lidocaine, polocaine), rater (1,2), and side (L, R). Table 5 shows
the results, and there was no significant difference between the three injections (P = 0.658).
The average VAS pain values for each of the groupings are shown in Table 6. The pain
levels are comparable and in the range from 12 to 17mm.
A repeated-measures mixed-model ANOVA was run with the following factors
considered: Study (articaine versus polocaine, lidocaine versus polocaine), injection (articaine,
lidocaine, polocaine), rater (1,2), side (L, R), sex (male, female), age (years). Table 7 shows the
results, and there was no significant difference between the three injections (P > 0.9). There was
also no left versus right side difference, no significant difference between the raters, no
relationship with age, no male versus female difference, and no difference between the subjects
in the two studies.
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Analysis of Numbness Duration
As a secondary aim, the study sought to compare the duration of numbness in the groups.
The minutes were analyzed using a repeated-measures mixed-model ANOVA with the following
factors: study (articaine versus polocaine, lidocaine versus polocaine), sequence (Artic Polo,
Polo Artic, Lido Polo, Polo Lido), and side (left, right). The results are shown in 8. In this case,
the results are clear. The differences between the epinephrine injection and the non-epinephrine
injection are similar across the two sequences (P = 0.427). The primary finding was a significant
difference between the numbness duration of the epinephrine injections and the non-epinephrine
injections (P < .0001).
The average duration of numbness in all the study groups is shown in Table 8. As may
be seen from the table, in all cases the articaine or lidocaine injections had longer duration than
did the polocaine injections.
Since the sequence/order of injections had no effect on numbness, the results may be
collapsed across these groups. These averages are shown in Table 9. The effects of polocaine
dissipated approximately wore off approximately an hour earlier.
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Discussion
A number of factors can be used to reduce the discomfort of a local anesthetic injection
such as pH buffering of an anesthetic solution, heating of an anesthetic solution, applying
pressure, controlling the speed of injection, use of appropriate needle gauge, relaxation
techniques, topical anesthetic, aspirating syringe, and an explanation of the procedure.2
However, there is little evidence in the literature that the various methods proposed are
dependable.
In addition to the techniques listed above, pH of the solution which is influenced by the
choice of anesthetic has been proposed as being significant in relation to injection pain. There is
evidence in the medical literature that pH influences injection discomfort.16 However, there is
little evidence in the dental literature that this occurs with intraoral anesthesia. Meechan noted
that the injection into the maxillary premolar buccal sulcus of lidocaine with epinephrine (lower
pH) produced more discomfort than plain lidocaine4. On the other hand, Wahl17 reported no
difference in injection discomfort during maxillary buccal infiltrations and inferior alveolar
nerve blocks with prilocaine plain versus lidocaine with 1:100,000 epinephrine.
This study was designed to determine the influence of different commercially available
local anesthetic solutions on injection discomfort in the mouth. All other parameters were
standardized. The plain solution had a pH closer to physiological than the epinephrinecontaining anesthetics. The results of this investigation differ with those of Meechan4. This may
be due to the different rate of injections. Meechan delivered 1.0 mL over 30 seconds whereas
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0.84 mL was delivered over the same period in this study. These findings are in agreement with
those of Wahl’s study17, which analyzed 334 injections in 310 patients using topical anesthetic
prior to administration of anesthetics. In this split-mouth pilot study, it was elected not to use
topical anesthetic to eliminate variations in the amount used and possible attenuation of pain.
The power analysis in Meechan’s study dictated that a sample size of 24 subjects
provided a 90% chance of detecting a 10-mm difference in the VAS at the 1% level4. However,
the carry-over effect eliminated the subjects being their own control for this split-mouth study.
Therefore, the number of subjects in this study (24 per study) may be too small to allow for
definitive conclusions.
In addition, it is apparent that injection discomfort varies in different areas of the mouth.
The maxillary buccal sulcus in the premolar area is usually considered a relatively comfortable
region for local anesthetic administration. Data was entered into the Meechan4 study only if one
or both scores on the pair were at least 30mm on the VAS because the sensitivity of the acute
pain trials is dependent on the production of moderate paint. This resulted in 50% of the
volunteers who did not achieve an injection discomfort score that merited inclusion in the study.
If the same VAS criteria were used, 83% of subjects would have been excluded. Low VAS
scores in this study, relative to Meechan’s study, may be due to the Wand delivering a more
comfortable injection method. Since we did not include palatal injections in our study, there
may be a difference in the pain response between anesthetics for this injection site.
Although the results of this investigation suggest no decrease in discomfort for the use of
plain polocaine solutions, this local anesthetic may be preferred for restoratives on the pediatric
patients. Epinephrine causes soft-tissue anesthesia that may last hours beyond completion of
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treatment.7 In this study, we found a statistically significant difference between duration of soft
tissue numbness of plain anesthetic versus epinephrine-containing anesthetic. Polocaine
averaged 87 minutes, articaine with epinephrine averaged 150 minutes, and lidocaine with
epinephrine averaged 152 minutes. This prolonged numbness can lead to accidental lip, cheek,
or tongue biting in children.7 To reduce the incidence of such soft-tissue injury, some clinicians
use 3% polocaine instead of 2% lidocaine-epinephrine.8 Although this study does not investigate
pulpal anesthesia, 3% polocaine has been found to be equivalent to other anesthetic solutions for
achieving pulpal anesthesia and inferior alveolar nerve blocks.6
This present study also showed a statistically significant order effect in relation to the
maxillary infiltration injections. The fact that the order of injection affects the injection pain
confirms results of other investigations on intraoral injection discomfort. For example, Martin18
found that patients who received bilateral buccal injections in the maxillary premolar region
reported the second injection to be significantly more uncomfortable than the first
administration. This implies the best chance of providing comfortable anesthetic delivery is at
the first injection. Thus, choosing an intraoral area where such possibility exists as the first site
of injection is supported. If additional administrations can be delivered into areas where the
initial anesthetic has spread, the overall pain experience for the patient might be reduced.
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Conclusion
There was no significant difference in the perceived pain on injection with plain polocaine
versus epinephrine containing anesthetics.
Under the methods of this study, regardless of which anesthetic administered, subjects
usually experienced only mild pain on injection.
Duration of soft tissue anesthesia for epinephrine-containing anesthetic was significantly
longer than plain polocaine which may increase the chances for soft tissue trauma.
Second injection was significantly more painful than the first injection.
Due to the carry-over effect, future split-mouth studies may not be justified.
Further study of the role of pH and injection pain is warranted.
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Table 1: Random Order of First Injection
First injection
Study N Side Product
Articaine vs Polocaine
7
L
Articaine
6
L
Polocaine
5
R
Articaine
5
R
Polocaine
Lidocaine vs Polocaine
7
L
Lido
6
L
Polocaine
6
R
Lido
6
R
Polocaine

Second injection
Side Product
R
R
L
L

Polocaine
Articaine
Polocaine
Articaine

R
R
L
L

Polocaine
Lido
Polocaine
Lido
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Table 2: Summary
Pain VAS
Sequence Injection Order
n Mean
SD
articaine vs polocaine subjects
Artic Polo Artic
1st
12 16.54
8.12
Polo
2nd
12 17.54
9.96
Artic-Polo
–1.00
Polo Artic Artic
2nd
11 20.27 16.25
Polo
1st
11 16.86 14.88
Artic-Polo
+3.41
lidocaine vs polocaine subjects
Lido Polo Lido
1st
13 12.69
8.82
Polo
2nd
13 19.38
9.88
Lido-Polo
–6.69
Polo Lido Lido
2nd
12 18.50 16.37
Polo
1st
12 12.13
7.66
Lido-Polo
+6.38
Abbreviations: SD=standard deviation, Artic=articaine, Polo=polocaine, Lido=lidocaine
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Table 3: ANOVA results
Effect
Num DF Den DF
F
P
Study
1
44
0.50 0.4822
Sequence
2
44
0.08 0.9259
Injection(Study)
2
138
0.32 0.7251
Rater
1
138
0.01 0.9346
Side
1
138
1.49 0.2243
Inject*Sequence(Study)
2
138 12.22 <.0001
Abbreviations: Num DF=numerator degrees of freedom, Den DF=denominator degrees of
freedom, F=F test, P=P-value
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Table 4: Average VAS Pain in Each Study Group
Pain VAS
Sequence Injection Order
n Estimate
SE
95% CI
P
articaine vs polocaine subjects
Artic Polo Artic
1st
12
16.44 3.17 10.09 22.79
Polo
2nd
17.65 3.17 11.30 23.99
Artic-Polo
–1.21 2.04
-5.23
2.82 0.5540
Polo Artic Artic
2nd
11
20.33 3.31 13.70 26.96
Polo
1st
16.81 3.31 10.18 23.44
Artic-Polo
+3.52 2.12
-0.67
7.71 0.0989
lidocaine vs polocaine subjects
Lido Polo Lido
1st
13
12.64 3.04
6.55 18.74
Polo
2nd
19.43 3.04 13.33 25.53
Lido-Polo
–6.79 1.95 -10.64 -2.93 0.0007
Polo Lido Lido
2nd
12
18.50 3.17 12.15 24.85
Polo
1st
12.13 3.17
5.78 18.47
Lido-Polo
+6.38 2.03
2.37 10.38 0.0020
Abbreviations: Artic=articaine, Polo=polocaine, Lido=lidocaine, SE=standard error,
CI=confidence interval, P=P-value

24

Table 5: ANOVA Results of the First Injection
Effect
Num DF Den DF
F P-value
Injection
2
44 0.42 0.6578
Rater
1
47 3.78 0.0579
Side
1
44 0.01 0.9162
Abbreviations: Num DF=numerator degrees of freedom, Den DF=denominator degrees of
freedom, F=F test, P=P-value
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Table 6: Average VAS pain of the First Injection, by Group
VAS Pain
Group Average
SE
95% CI
Injection
Artic
16.57 3.04 10.44 22.70
Lido
12.70 2.92
6.83 18.58
Polo
14.40 2.19
9.98 18.82
Rater
1
14.61 1.59 11.41 17.81
2
14.51 1.59 11.31 17.70
Side
L
14.40 2.10 10.17 18.62
R
14.72 2.30 10.09 19.35
Abbreviations: Artic=articaine, Polo=polocaine, Lido=lidocaine, SE=standard error,
CI=confidence interval
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Table 7: alternate ANOVA Results of the First Injection
Source
Side
Rater
Age
Sex
Study
Injection[Study]

Num
DF
1
1
1
1
1
2

Den
DF
41
47
41
41
41
41

F
0.12
3.78
3.19
1.62
1.96
0.05

Pvalue
0.7258
0.0579
0.0814
0.2104
0.1691
0.9516
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Table 8: ANOVA results of Numbness
Effect
Num DF Den DF
F
P
Study
1
44
0.02 0.8883
Sequence(Study)
2
44
0.73 0.4862
Injection(Study)
2
43 19.49 <.0001
Side
1
43
0.36 0.5529
Inject*Sequence(Study)
2
43
0.87 0.4274
Abbreviations: Num DF=numerator degrees of freedom, Den DF=denominator degrees of
freedom, F=F test, P=P-value
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Table 9: Average Duration for all Study Groups
Duration (minutes)
Sequence Injection Order
n Estimate
SE
95% CI
P
articaine vs polocaine subjects
Artic Polo Artic
1st
12
162.43 15.32 131.98 192.87
Polo
2nd
87.91 15.32
57.46 118.35
Artic-Polo
74.52 20.48
33.22 115.82 0.0007
Polo Artic Artic
2nd
11
137.45 15.98 105.68 169.21
Polo
1st
86.19 15.98
54.42 117.95
Artic-Polo
51.26 21.34
8.23
94.29 0.0207
lidocaine vs polocaine subjects
Lido Polo Lido
1st
13
137.85 14.70 108.63 167.07
Polo
2nd
88.15 14.70
58.93 117.37
Lido-Polo
49.70 19.62
10.13
89.28 0.0150
Polo Lido Lido
2nd
12
167.00 15.29 136.60 197.40
Polo
1st
87.42 15.29
57.02 117.82
Lido-Polo
79.58 20.41
38.43 120.74 0.0003
Abbreviations: Artic=articaine, Polo=polocaine, Lido=lidocaine, SE=standard error,
CI=confidence interval, P=P-value

29

Table 10: Average Duration for the Injection Groups
Duration (minutes)
Injection Estimate
SE
95% CI
P
articaine vs polocaine subjects
Artic
149.94 11.06 127.96 171.92
Polo
87.05 11.06
65.06 109.03
62.89 14.76
33.12
92.66 0.0001
lidocaine vs polocaine subjects
Lido
152.43 10.61 131.34 173.51
Polo
87.78 10.61
66.70 108.86
64.64 14.16
36.09
93.19 <.0001
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Figure 1: Individual VAS Pain Ratings in the Two Groups of Subjects
Articaine Study Subjects
a)

b)

Lidocaine Study Subjects
c)

d)
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Figure 2: Average VAS Pain in Each Study Group
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Comparison of Intraoral Injection Pain from Plain Polocaine versus Epinephrine-Containing
Articaine Local Anesthetic Solutions

Health History Form
Name:_________________ Contact number:______________ Date of Birth:____________
Are you presently in good general health?

□ yes

□ no

If no, please explain:_______________________________________________________
Are you under the care of a physician?

□ yes

□ no

If no, please explain:_______________________________________________________
Have you been admitted to the hospital?

□ yes

□ no

If yes, please explain:______________________________________________________
Have you had any surgeries?

□ yes

□ no

If yes, please explain:______________________________________________________
Do you have any heart problems?

□ yes

□ no

If yes, please explain:______________________________________________________
Do you have any breathing problems?

□ yes

□ no

If yes, please explain:______________________________________________________
Do you have any blood related problems?

□ yes

□ no

If yes, please explain:______________________________________________________

□ yes

Do you have any head, ear, eye, nose, or throat problems?

□ no

If yes, please explain:______________________________________________________
Do you have any digestive problems?

□ yes

□ no

If yes, please explain:______________________________________________________
Do you have any endocrine problems (such diabetes, thyroid, etc)?

□ yes

□ no

If yes, please explain:______________________________________________________
Do you have any nervous system problems (stroke, epilepsy, etc)?

□ yes

□ no

If yes, please explain:______________________________________________________
Do you have any psychiatric problems?

□ yes
33

□ no

If yes, please explain:______________________________________________________
Do you have any other health concerns?

□ yes

□ no

If yes, please explain:______________________________________________________
For women only – are you currently nursing/pregnant?

□ yes

□ no

Family History – cancer, arthritis, neurologic, heart disease, hypertension, anesthesia
complications?
________________________________________________________________________
________________________________________________________________________
Social History – smoking/tobacco use, alcoholic beverages, and/or recreational drugs?
________________________________________________________________________
________________________________________________________________________
Allergies – Food or drug?
________________________________________________________________________
________________________________________________________________________
Medications?
________________________________________________________________________
________________________________________________________________________
Have you taken any analgesics within the past 72 hours?
________________________________________________________________________
________________________________________________________________________
Have you ever had complications from local anesthetics (numbing medication) in the past?
________________________________________________________________________
________________________________________________________________________
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Comparison of Injection Discomfort and Anesthetic Duration of Plain Polocaine versus
Epinephrine containing Articaine and Lidocaine

Dental Resident (Dana Doan, DDS) Script for Study Participation:
You are being asked to participate in a study for my research project.
The purpose of this study is to determine if there is a difference in the discomfort and anesthetic
duration commonly experienced by patients following the injection of plain polocaine versus
epinephrine containing articaine or lidocaine.
Immediately after the two local anesthetic administration, you will be asked to record injection
discomfort on a continuous 100-mm visual analogue scale (VAS) with endpoints "no pain" and
"unbearable pain. You will also be asked to record the times at which soft tissue anesthesia
wears off for both sides.
Personal information will be collected concerning your health history and the information will be
kept anonymous and secure.
Your participation is voluntary - meaning you may stop or withdraw from the study at any point.
Volunteering for this study will not affect or change your grade for the pediatric dentistry
rotation.
Your participation will potentially help pediatric dentists reduce patient’s discomfort associated
with injections.
You will be compensated $20 for your participation after both injections are completed, you have
provided the requested feedback on your pain level, and the requested feedback on durations at
which the soft tissue anesthesia wears off.
If you choose to participate, read over the Consent Form and sign it after all of your questions
have been answered. Also, fill out the Health History Form.
Thank you for your time and participation with this study.
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Comparison of Injection Discomfort and Anesthetic Duration of Plain Polocaine
versus Epinephrine containing Articaine and Lidocaine

Anesthetic Duration Sheet

Subject # _______

Time of 1st injection: ______________

Left/Right

Time soft tissue anesthesia for Left/Right side wears off: ______________

Time of 2nd injection: ______________

Left/Right

Time soft tissue anesthesia for Left/Right side wears off: ______________
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